Kelly Financial Services LLC T2 Biosystems, Inc. Transaction History

Kelly Financial Services LLC

  • $258 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jul 17, 2024
SELL
$1.06 - $545.0 $1,687 - $867,640
-1,592 Closed
0 $0
Q3 2021

Jul 17, 2024
SELL
$0.86 - $1.21 $259 - $365
-302 Reduced 15.95%
1,592 $1.46 Million
Q2 2021

Jul 17, 2024
BUY
$1.04 - $1.69 $314 - $510
302 Added 18.97%
1,894 $1.59 Million
Q1 2019

Jul 17, 2024
BUY
$2.56 - $4.48 $4,075 - $7,132
1,592 New
1,592 $4.19 Million

About T2 Biosystems, Inc.

TTOO Quotes by TradingView
  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $5.08M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email